Zymergen, Inc. (ZY)
|Net Income (ttm)||-262.19M|
Zymergen Inc, backed by SoftBank Group Corp Inc's Vision Fund, is looking to raise around $100 million through an initial public offering in the United States, according to a regulatory filing on T...
Zymergen, Inc. has filed to go public with an IPO on the NASDAQ.
Zymergen partners with Nature to design, develop, and commercialize bio-based breakthrough products that deliver extraordinary value to customers in a broad range of industries. Our first innovations include films designed for electronics companies to use in new categories of smart devices, including rollable tablets and naturally derived UV protection. We create new products with a proprietary platform that unlocks the design and manufacturing efficiency of biological processes with technology’s ability to rapidly iterate and control diverse... [Read more...]
Commercial Physical & Biological Research
|IPO Date |
|Stock Exchange |
|Ticker Symbol |
In 2020, Zymergen's revenue was $13.28 million, a decrease of -13.85% compared to the previous year's $15.42 million. Losses were -$262.19 million, 10.7% more than in 2019.